Where NT-proBNP is reported
Also listed as: Natriuretic peptide
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Atrial Fibrillation | ↑ elevated | cardiac stress/AF vs healthy | — | Panagopoulou et al. 2013 |
| Hypertension | ↑ elevated | hypertensive (asymptomatic, at-risk) vs normal | — | Bayes-Genis et al. 2023 |
| Long COVID | ↑ elevated | healthy controls | Cardiovascular LC | Thomas et al. 2024 |
Frequently asked questions
In which conditions is NT-proBNP altered?
In the OSMF atlas NT-proBNP is reported in Atrial Fibrillation, Hypertension, Long COVID. It is elevated in 3 across 3 entries.
Does NT-proBNP point to one specific diagnosis?
No. Because NT-proBNP changes in several conditions (Atrial Fibrillation, Hypertension, Long COVID), an abnormal result cannot identify which condition, if any, is present. It must be interpreted with symptoms, history and other tests.
What is the LOINC code for NT-proBNP?
Entries in this atlas use LOINC 33762-6. LOINC codes identify the laboratory observation so results can be compared across systems.
Is one abnormal NT-proBNP result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Subscribe on Substack
Last reviewed: 2026-07-03 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.